Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials

Autor: Ryo Kameda, Masayasu Ikutomi, Absorb, M. Brooke Hollak, Yasuhiro Honda, Krishnankutty Sudhir, Jeffrey J. Popma, Paul G. Yock, Takeshi Kimura, Hajime Kusano, Stephen G. Ellis, Hideki Kitahara, Dean J. Kereiakes, Takeshi Nishi, Kozo Okada, Wai-Fung Cheong, Peter J. Fitzgerald, Shinji Imura, Gregg W. Stone

Publikováno v: Journal of Cardiology. 78:224-229

Background The long-term prognostic impact of IVUS findings following Absorb BVS implantation remains uncertain. This study aimed to identify the IVUS predictors of long-term clinical outcomes following ABSORB bioresorbable vascular scaffold (BVS) im

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08dda5ceb669afa619f52824ec637695
https://doi.org/10.1016/j.jjcc.2021.03.005

Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque

Autor: Akiko Maehara, Ovidiu Dressler, Ori Ben-Yehuda, Ziad A. Ali, Mitsuaki Matsumura, Ulf Jensen, Thor Trovik, Gary S. Mintz, Thomas Engstrøm, Prospect Absorb Investigators, Jonas Persson, Stefan James, Claes Held, Hans Erik Bøtker, Rune Wiseth, Aaron Crowley, Michael Maeng, Lars Kjøller-Hansen, David Erlinge, Gregg W. Stone

Publikováno v: Stone, G W, Maehara, A, Ali, Z A, Held, C, Matsumura, M, Kjøller-Hansen, L, Bøtker, H E, Maeng, M, Engstrøm, T, Wiseth, R, Persson, J, Trovik, T, Jensen, U, James, S K, Mintz, G S, Dressler, O, Crowley, A, Ben-Yehuda, O, Erlinge, D & PROSPECT ABSORB Investigators 2020, ' Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque ', Journal of the American College of Cardiology, vol. 76, no. 20, pp. 2289-2301 . https://doi.org/10.1016/j.jacc.2020.09.547
Stone, G W, Maehara, A, Ali, Z A, Held, C, Matsumura, M, Kjøller-hansen, L, Bøtker, H E, Maeng, M, Engstrøm, T, Wiseth, R, Persson, J, Trovik, T, Jensen, U, James, S K, Mintz, G S, Dressler, O, Crowley, A, Ben-yehuda, O & Erlinge, D 2020, ' Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque ', Journal of the American College of Cardiology, vol. 76, no. 20, pp. 2289-2301 . https://doi.org/10.1016/j.jacc.2020.09.547

BACKGROUND: Acute coronary syndromes most commonly arise from thrombosis of lipid-rich coronary atheromas that have large plaque burden despite angiographically appearing mild.OBJECTIVES: We sought to examine the outcomes of percutaneous coronary int

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afbe2649ea8d942484be55b0fe12b51b
https://doi.org/10.1016/j.jacc.2020.09.547

Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial

Autor: Divine E. Ediebah, Robert Whitbourn, Patrick W. Serruys, Krishnankutty Sudhir, Antonio L. Bartorelli, J. Ribamar Costa, Alexandre Abizaid, Nigel Jepson, Absorb Extend investigators, Marrianne Stuteville, Clemens Steinwender

Publikováno v: Catheterization and Cardiovascular Interventions. 93:E1-E7

Background There is still limited data on the very long term clinical outcomes after ABSORB BRS in daily practice. We sought to evaluate the 3 year-performance of the Absorb bioresorbable vascular scaffolds for the treatment of low/moderate complexit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::232a0023e09bee992098fe5ed199915d
https://doi.org/10.1002/ccd.27715

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds

Autor: David G. Rizik, Robert McGreevy, Christopher Metzger, Jeffrey J. Popma, Steven O. Marx, Stephen G. Ellis, Ronald P. Caputo, Charles A. Simonton, Marc Litt, Dean J. Kereiakes, Ameer Kabour, Paul S. Teirstein, Absorb Iii Investigators, Gregg W. Stone, Annapoorna Kini, Zhen Zhang

Publikováno v: Journal of the American College of Cardiology. 70:2852-2862

Background The Absorb everolimus-eluting poly-L-lactic acid–based bioresorbable vascular scaffold (BVS) provides early drug delivery and mechanical support functions similar to metallic drug-eluting stents (DES), followed by complete bioresorption

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::51a0c040be3177384d63752e16b3cc70
https://doi.org/10.1016/j.jacc.2017.10.010